Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Us 8 158 616 b2 baricitinib synthesis?Kcentra vs vitamin k?Inj tenecteplase price?Us8158616b2 baricitinib google patents?Us8158616b2 baricitinib patent synthesis steps?
See the DrugPatentWatch profile for Enjuvia
Enjuvia, a brand of docusate sodium, has been discontinued by its manufacturer, Procter & Gamble [1]. This medication was used as a stool softener.
The discontinuation of Enjuvia is attributed to business decisions by Procter & Gamble [1]. Specific details regarding the exact reasons for the business decision were not provided.
Since Enjuvia has been discontinued, individuals seeking a stool softener may consider other docusate sodium products or alternative laxatives. Docusate sodium is available under various brand names and as a generic option [2]. Other types of laxatives include bulk-forming agents, osmotic laxatives, and stimulant laxatives, each working through different mechanisms to relieve constipation [3].
Information on stool softeners, laxatives, and their availability can be found through healthcare providers and pharmaceutical resources. DrugPatentWatch.com provides information on drug patents and market exclusivity, which can be relevant to understanding the availability and market landscape of medications [4].
Other Questions About Enjuvia :